• MILITARY: Brazil-France submarine programme (Graphic DUE Mar 28, 15:00GMT)
  • SPACE: Calls for protected moon sites (Graphic DUE Mar 28, 16:00GMT)
  • ACCIDENT: Why did Baltimore bridge collapse? (Graphic DUE Mar 28, 17:30GMT)
  • For full details of graphics available/in preparation, see Menu -> Planners
 Desarrollo de vacunas infographic
El gráfico muestra las etapas de desarrollo de las vacunas.
GN40087ES

SALUD

Etapas de desarrollo de vacunas

By Duncan Mil

March 17, 2020 - La carrera por hallar una vacuna para el brote de coronavirus está en marcha pero las vacunas pasan por múltiples etapas de desarrollo – desde su descubrimiento hasta pruebas con animales, pruebas con humanos, aprobación de autoridades y fabricación.

The Norway-based Coalition for Epidemic Preparedness Innovations (CEPI), made up of vaccine makers and health agencies -- is leading the bid to fast-track a vaccine.

Researchers in the U.S. at Massachusetts-based Moderna, a CEPI-sponsored start-up, began developing a “nucleic acid vaccine.” The vaccine contains the genetic recipe for human recipients to generate antigens -- in this case SARS-CoV-2 viral fusion proteins -- inside their body. These antigens then trigger the immune system to produce antibodies to block the virus.

Forty-five young, healthy volunteers began participating in a trial of Moderna’s vaccine at the Kaiser Permanente Washington Health Research Institute in Seattle on March 16.

A CEPI-sponsored team in Australia is also using the “spike protein” on the outside of the virus. The viral spike protein binds to a receptor on the human cell surface called ACE2 (Angiotensin-converting enzyme 2).

Before being injected into humans, a candidate vaccine goes through pre-clinical trials in which experiments on animals determine whether treatments are safe and effective.

In the next phase, a lengthy series of clinical trials evaluate the vaccine’s safety and ability to generate an immune system response.

The production of a vaccine for large-scale use could take 12–18 months and might not be possible during the current outbreak, explains Nicola Stonehouse, a professor in molecular virology at the University of Leeds. “What it might do is help control future outbreaks,” she says. “To make a vaccine conventionally -- to test it and get it on the market -- can take a decade.”

Sources
PUBLISHED: 17/03/2020; STORY: Graphic News
Advertisement